Rashmi Ranjan Sarangi
VIDWAN ID: 385439

Prof Rashmi Ranjan Sarangi

Male Doctor of Philosophy
Professor
Royal College of Pharmacy and Health Sciences (RCPHS), Berhampur
Odisha
Expertise: Pharmacology and Pharmacy
3 Publications
1 Projects
29 Scopus Citations
16 CrossRef
32 Years 1 Month Total Experience
Publications
3 Total
Articles
3
Activity

No publication activity to display.

Scopus Scopus
29 Citations
2 h-index
CrossRef CrossRef
16 Citations
1 h-index
Google Scholar Google Scholar

Loading Scholar statistics...

Professional Recognition

No Data Found

There is currently nothing to display here.

Community & Membership

Student Council, RCPHS,Berhampur
Chairman
Jan 2016
Antiragging Squard of RCPHS Berhampur
Convenor
Jan 2016
Association of Pharmacy teachers of India
OR/LM-149
Jan 2007
Indian Pharmacy Graduates' Association in New Delhi, India
Life Member
Jan 2023

Personal Details

Doctor of Philosophy
2012
UNIVERSITY OF CALCUTTA
Master of Pharmacy
2006
National Institute of Cholera and Enteric Diseases
Bachelor of Pharmacy
1993
N/A
Professor
Aug 2006 – Present
Royal College of Pharmacy and Health Sciences (RCPHS), Berhampur
Adjunct Lecturer
Aug 1994 – Aug 2006
College of Pharmaceutical Sciences (CPS), Puri
Medical and Health Sciences
Pharmacology and Pharmacy

Related Profiles

Scholarly Work

WEDP
Other
Agency: Department of Science and Technology Role: Co-Principal Investigator
No Data Found

There is currently nothing to display here.

Portable Tablet Dissolution Apparatus

Dr. Madhusmruti Khandai
Dr. Rashmi Ranjan Sarangi
Dr. Sanjay Kumar Nayak
Dr. Gourishyam Pasa
Mr. Subhransu Bhusana Palatasingh
Mr. Anshuman Gouda
- Patent No. : 24-02 Filed : 06-06-2023
Published : 25-09-2023 Granted

Scholarly Publications

Carbon Nanostructures as Therapeutic Cargoes: Recent Developments and Challenges

Open Access
Journal Article
C. Year: 2023. Volume: 9 , Issue: 1 , Pages: 3 .
Authors: Singh, Jagtar; Nayak, Pallavi; Singh, Gurdeep; Khandai, Madhusmruti; Sarangi, Rashmi Ranjan; Kar, Mihir Kumar

Investigation of N-(5-nitrothiazol-2-yl)-2-((4-oxo-3,4-Dihydroquinazolin-2-yl) Thio) Acetamide Derivatives as Potential EGFR Kinase Inhibitors

Journal Article
Year: 2025. Volume: 8 , Issue: 8 , Pages: 1398-1430 .

Comparative in vitro antimicrobial activity studies of Sida rhombifolia Linn fruit extracts

Journal Article
Authors: Sarangi, R.R.; Mishra, U.S.; Choudhury, P.K.